Evidence map›Paper›PMID 39099945›Full record

ReviewCureus2024

Alternatives for the Detection and Diagnosis of Osteoarticular Infections: An Exploratory Review.

Esteban Zavaleta-Monestel, Mariela Alpizar-Rojas, Jonathan García-Montero, Alexa León-Obando, Sebastián Arguedas-Chacón, Ricardo Quesada-Villaseñor

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Esteban Zavaleta-MonestelPharmacy, Hospital Clínica Bíblica, San José, CRI.
Mariela Alpizar-RojasPharmacy and Nuclear Medicine, Hospital Clínica Bíblica, San José, CRI.
Jonathan García-MonteroPharmacy and Clinical Research, Hospital Clínica Bíblica, San José, CRI.
Alexa León-ObandoPharmacy, Universidad de Iberoámerica, San José, CRI.
Sebastián Arguedas-ChacónPharmacy and Clinical Research, Hospital Clínica Bíblica, San José, CRI.
Ricardo Quesada-VillaseñorMedical Research, Hospital Clínica Bíblica, San José, CRI.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The precise diagnosis of osteomyelitis, a bone infection, remains a significant challenge for healthcare professionals. This difficulty stems from the highly variable nature of its clinical presentation and disease course. Patients can exhibit a wide range of symptoms, making it easy to misdiagnose the condition. In turn, inaccurate diagnoses lead to inappropriate treatment regimens, potentially hindering a patient's recovery and causing unnecessary complications. Nuclear medicine offers a ray of hope in this fight against diagnostic ambiguity. It provides valuable tools, such as radiopharmaceutical imaging, that can significantly improve the accuracy of osteomyelitis diagnosis. However, limitations exist. This article explores the need for alternative diagnostic approaches within the specific context of Costa Rica. This exploration is particularly relevant due to the current regional shortage of gallium-67 (⁶⁷Ga), a radiopharmaceutical commonly used in osteomyelitis diagnosis. The article delves into the nature, function, and limitations of various nuclear medicine techniques, encompassing both independent radiopharmaceuticals like ⁶⁷Ga and those conjugated with specific targeting molecules to pinpoint areas of infection within the body. Given the scarcity of ⁶⁷Ga in Costa Rica, it becomes crucial to explore and implement viable alternative diagnostic techniques within the healthcare system. This article emphasizes the need for further investigation into these alternatives, with the goal of improving diagnostic accuracy and ensuring optimal patient care. By implementing these alternatives, healthcare professionals in Costa Rica can effectively combat the challenges posed by osteomyelitis and pave the way for better patient outcomes.

Indexed as

99mtc-ciprofloxacingallium-67infectionosteoarticular diseaseosteomyelitistechnetium-99m

Identifiers

PMID39099945
PMCPMC11296701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.